19 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterGenome binding/occupancy profiling by high throughput sequencing Remove filterBW Remove filterKornelia Polyak
GSE104988
KDM5B links cellular transcriptome heterogeneity to therapy resistance
333 Kornelia Polyak Oct 03, 2018
GSE131102
Synthetic lethal and resistance interactions with BET bromodomain inhibitors
210 Kornelia Polyak Mar 30, 2020
GSE38548
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer
106 Kornelia Polyak Jun 09, 2015
GSE202776
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer
386 Kornelia Polyak Nov 09, 2023
GSE69112
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [ChIP-Seq 3]
  • Genome binding/occupancy profiling by high throughput sequencing
23 Kornelia Polyak Jun 10, 2015
GSE104983
KDM5B links cellular transcriptome heterogeneity to therapy resistance (ChIP-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
171 Kornelia Polyak Oct 03, 2018
GSE131026
Synthetic lethal and resistance interactions with BET bromodomain inhibitors [ATAC-Seq]
  • Genome binding/occupancy profiling by high throughput sequencing
16 Kornelia Polyak Mar 30, 2020
GSE131097
Synthetic lethal and resistance interactions with BET bromodomain inhibitors [ChIP-Seq]
  • Genome binding/occupancy profiling by high throughput sequencing
61 Kornelia Polyak Mar 30, 2020
GSE163360
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states [ChIP-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
14 Kornelia Polyak Nov 02, 2022
GSE163397
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states
131 Kornelia Polyak Nov 02, 2022
GSE202766
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (H3K27ac cell lines ChIP-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
60 Kornelia Polyak Nov 09, 2023
GSE202767
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PRRX1 ChIP-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
31 Kornelia Polyak Nov 09, 2023
GSE202772
Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
24 Kornelia Polyak Nov 09, 2023
GSE229426
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer [ATAC-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
12 Kornelia Polyak Aug 15, 2023
GSE229428
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer
34 Kornelia Polyak Aug 15, 2023
GSE237390
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 [ChIP-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
54 Kornelia Polyak Apr 24, 2024
GSE237392
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3
81 Kornelia Polyak Apr 24, 2024
GSE249459
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies [ATAC-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
24 Kornelia Polyak Apr 24, 2024
GSE249574
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies
64 Kornelia Polyak Apr 24, 2024